Page 13 - IJB-10-5
P. 13

International Journal of Bioprinting                                3D bioprinting for nanoparticle evaluation




            Table 3. Bioprinted models for inflammatory disease, toxicity, drug release, and tissue engineering.
             Printed    Used NPs       Used drug   Cell line  Main materials of   Bioprinting   NPs evaluation study  Ref.
             model                                          bioink        method
             Inflammatory   Albumin NPs  Roxadustat,   Caco-2,   Polysaccharide   Extrusion-  Transepithelial electrical   101
             disease                   caffeic acid   HT29  components,   based      resistance
                                       phenethyl ester      alginate, hydrated   bioprinting
                                                            cellulose nanofibrils
             Toxicity   Copper oxide NP   N/A      Human    Porcine gelatin,   µCOP system  Gene expression related   112
                        coated with bovine         iPSCs    methacrylic              to mitochondrial
                        serum albumin                       anhydride                biogenesis, cell viability
                        Polydispersity   N/A       Calu-3   Alginate/gelatin/  Extrusion-  Toxicity      115
                        colloidal silver NP,                Matrigel      based
                        atoxic carboxyl-                                  bioprinting
                        modified fluorescent
                        NP
             Drug release  Dextran sulfate,   Minocycline   L929   GelMA  Extrusion-  Drug release       123
                        magnesium ions  hydrochloride  fibroblast         based
                                                                          bioprinting
             Tissue     N-vinylcaprolactam,   Catechol  L929  CMCh, HAox  Extrusion-  Cell viability     131
             engineering   2-hydroxyethyl                                 based
             and        methacrylate                                      bioprinting
             regenerative
             medicine
            Abbreviations: CMCh: Carboxymethyl chitosan; GelMA: Gelatin methacryloyl; HAox: Oxidized hyaluronic acid; NP: Nanoparticle;
            µCOP: Micro-continuous optical printing.

                                                                                                    35
            2.2. Three-dimensional printed tumor models        characteristic of the tumor microenvironment.  This pH-
            with alginate-gelatin-nanoclay scaffolds for       responsive drug release enhances the targeting efficiency of
            evaluating curcumin-loaded nanoparticles in breast   the NPs, potentially leading to better therapeutic outcomes
            cancer therapy                                     with reduced side effects. The researchers also demonstrated
            The study by Su et al.  presents an innovative approach   that CurNPs exhibited significant cytotoxicity against
                              36
            that combines curcumin-loaded NPs (CurNPs) with    breast cancer cells in the 3D tumor models. The 3D
            3D-printed bionic tumor models to evaluate and enhance   models supported cell proliferation and more accurately
            breast cancer treatment. The researchers utilized 3D   reflected the characteristics of tumor cells, providing
            cell culture models to create a more realistic tumor   high reliability in drug screening and therapeutic efficacy
            microenvironment, thereby addressing the limitations of   evaluation. This study indicates that the combination of
            conventional 2D culture methods. To synthesize CurNPs,   CurNPs with 3D-printed tumor models presents a novel
            the  researchers  encapsulated  curcumin,  a  traditional   approach to breast cancer treatment, overcoming the
            anticancer agent, in a polymer (Pluronic® F127) using   limitations of traditional therapies and contributing to
            the nanoprecipitation method.  This process produced   the development of more effective treatment strategies.
                                     34
            NPs with excellent water solubility and biocompatibility.   Thus, Su et al.  have shown that merging NPs with 3D
                                                                           36
            CurNPs demonstrated significant anticancer effects   bioprinting technology opens new possibilities for breast
            against breast cancer cells (MDA-MB-231), showing high   cancer treatment evaluation.
            internalization and excellent cytotoxicity.
                                                               2.3. Three-dimensional bioprinted GelMA constructs
               To create realistic 3D tumor models, Su et al.  prepared   for photothermal therapy with keratin-coated gold
                                                  36
            hybrid scaffolds using sodium alginate, gelatin, and   nanoparticles in glioblastoma treatment
            nanoclay. These materials were selected for their printability   Chirivì et al.  conducted an innovative study integrating
                                                                         37
            and mechanical properties, crucial for maintaining the   biomimetic keratin-coated gold NPs (Ker-AuNPs)
            structure and function of the 3D models. The printed   with advanced 3D bioprinting technology to develop
            scaffolds exhibited strong mechanical properties through   a glioblastoma tumor model for photothermal therapy
            rapid  crosslinking,  making  them  suitable  for  long-term   (PTT) (Figure 2). This approach offers a compelling
            cell culture. Experimental results showed that CurNPs   alternative to traditional 2D culture systems, enabling
            had a higher release rate in acidic conditions, which is   more realistic tumor models that better mimic the complex


            Volume 10 Issue 5 (2024)                        5                                 doi: 10.36922/ijb.4273
   8   9   10   11   12   13   14   15   16   17   18